Addressing conflict in strategic literature reviews: Disclosure is not enough

Journal of Epidemiology and Community Health

Volumn 63, Issue 8, 2009, Pages 599-600

  Michaels, David ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CIGARETTE SMOKE; INDUSTRIAL CHEMICAL; MANGANESE;

CONFLICT MANAGEMENT; ENVIRONMENTAL HAZARD; HEALTH IMPACT; INFORMATION POLICY; LITERATURE REVIEW; MEDICINE; META-ANALYSIS; PUBLIC HEALTH; SMOKING; STRATEGIC APPROACH;

DANGEROUS GOODS; FUNDING; HEALTH HAZARD; INTERPERSONAL COMMUNICATION; MEDICINE; NEUROLOGIC DISEASE; PUBLIC HEALTH SERVICE; REVIEW;

BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; DISCLOSURE; HAZARDOUS SUBSTANCES; HUMANS; META-ANALYSIS AS TOPIC; METALLURGY; PUBLICATION BIAS; RESEARCH SUPPORT AS TOPIC; REVIEW LITERATURE AS TOPIC; SOCIAL JUSTICE; TOBACCO INDUSTRY; UNCERTAINTY;

EID: 67651236342     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2009.089524     Document Type: Review

References (24)

1. Brandt AM. The cigarette industry: the rise, fall, and deadly persistence of the product that defined America. New York: Basic Books, 2007.
2. Glantz S, Slade J, Bero L, et al. The cigarette papers. Berkeley: University of California Press, 1996.
3. Michaels D. Doubt is their product: how industry's assault on science threatens your health. New York: Oxford University Press, 2008.
4. Morris J. Welding's toxic legacy. The center for public integrity. http://projects.publicintegrity.org/Manganese/Default.htm (accessed 23 May 2009).
5. Schneider A. Pressure at OSHA to alter warning. The Sun (Baltimore) 2006; 20 Nov.
6. Michaels D, Monforton C. How Litigation shapes the scientific literature: asbestos and disease among automobile mechanics. J Law Policy 2007;5:1137-69.
7. Boden LI, Ozonoff D. 2007. Litigation-generated science: why should we care? Environ Health Perspect 2008;116:117-22.
8. Krimsky S. The funding effect in science and its implications for the judiciary. J Law Policy 2005;13:43-68.
9. Barnes DE, Bero LA. Why review articles on health effects of passive smoking reach different conclusions. JAMA 1998;279:1566- 70.
10. Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 2003;326:1167-70.
11. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2005;2:364-6.
12. vom Saal FS, Welshons WV. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ Res 2006;100:50-76.
13. Kriebel D. Reanalysis: lessons great and small. Occup Environ Med 2008;65:368-70.
14. International Agency for Research on Cancer. Silica, some silicates, coal dust and para-aramid fibrils. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol 68.Lyon: IARC, 1997.
15. Report on Carcinogens, 11th edn. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. http://ntp.niehs.nih.gov/ntp/roc/tocll.html (accessed 3 Jun 2009).
16. Hessel PA, Gamble JF, Gee JB, et al. Silica, silicosis, and lung cancer: a response to a recent working group report. J Occup Environ Med 2000;42:704-20.
17. Harber P, Saechao K, Boomus C. Diacetyl-induced lung disease. Toxicol Rev 2006;25:261-72.
18. Kreiss K. Flavoring-related bronchiolitis obliterans. Curr Opin Allergy Clin Immunol 2007;7:162-7.
19. Michaels D, Monforton C. Scientific evidence in the regulatory system: manufacturing uncertainty and the demise of the formal regulatory system. J Law Policy 2005;13:17-41.
20. Galbraith DA, Weill D. Popcorn lung and bronchiolitis obliterans: a critical appraisal. Int Arch Occup Environ Health 2009;82:407- 16.
21. Godlee F. The ethics of peer review. In: Ethical Issues in biomedical publication. Jones AH, McLellan F, eds. Baltimore: Johns Hopkins University Press, 2000:59-84.
22. Angell M, Kassirer JP. Editorials and conflicts of interest. N Engl J Med 1996;335:1055-6.
23. Relman AS. New "information for authors" - and readers. N Engl J Med 1990;323:56.
24. Drazen JM, Curfman GD. Financial associations of authors. N Engl J Med 2002;346:1901-2.